ORCHID PHARMA LTD Announces Quarterly Results (2QFY19); Net Profit Up 67.1%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ORCHID PHARMA LTD Announces Quarterly Results (2QFY19); Net Profit Up 67.1%
Thu, 31 Jan

ORCHID PHARMA LTD has announced its results for the quarter ended September 2018. Here is a detailed performance review of the same:

ORCHID PHARMA LTD Quarterly Financials

No. of Mths
Qtr. Ending
3
Sep-17*
3
Jun-18*
3
Sep-18*
QoQ ChangeYoY Change
Net SalesRs m2,0931,3061,4259.1%-31.9%
Other incomeRs m47436347.1%33.1%
TurnoverRs m2,1411,3491,48810.3%-30.5%
ExpensesRs m1,8561,4491,4570.6%-21.5%
Gross profitRs m238-3935-85.1%
DepreciationRs m3363283300.5%-2.0%
InterestRs m7551350-100.0%-100.0%
Profit before taxRs m-806-460-231
TaxRs m-10300-200.0%
Profit after taxRs m-703-460-231
Gross profit margin%11.4-3.02.5
Effective tax rate%12.70.00.0
Net profit margin%-32.9-34.1-15.5
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter fell 31.9% on a year-on-year (YoY) basis. The expenses were down by 21.5% YoY during the same period.
  • The company's operating profit declined by 85.1% YoY during the quarter. Consequently, operating profit margins witnessed a decline and stood at 2.5% in 2QFY19 as against 11.4% in 2QFY18.
  • Depreciation charges declined by 2.0% and finance costs declined by 100.0% YoY, respectively.
  • Other income increased by 33.1% YoY during the quarter.
  • Net profit for the quarter increased by 67.1% YoY. Net profit margins during the quarter increased from -32.9% in 2QFY18 to -15.5% in 2QFY19.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter grew 9.1% on a quarter-on-quarter (QoQ) basis. The expenses were up by 0.6% QoQ during the same period.
  • The company's operating profit increased by 190.2% QoQ during the quarter. Consequently, operating profit margins witnessed a growth and stood at 2.5% in 2QFY19 as against 3.0% in 1QFY18.
  • Net profit for the quarter increased by 49.7% QoQ, while net profit margins increased from -34.1% in 1QFY18 to -15.5% in 2QFY19.

To see how ORCHID PHARMA LTD has performed over the last eight quarters, please visit here.

ORCHID PHARMA LTD Share Price Performance

Over the last one year, ORCHID PHARMA LTD share price has moved up from Rs 17.7 to Rs 4.3, registering a Loss of Rs 13.4 or around 75.8%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 13,860.8 (up 0.7%). Over the last one year it has moved down from 14,559.4 to 13,860.8, a gain of 699 points (down 4.8%).

Overall, the S&P BSE SENSEX is up 0.4% over the year.

Current Valuations

At the current price of Rs 4.3, the price to book value (P/BV) ratio of ORCHID PHARMA LTD stands at 0.1 times.

Equitymaster requests your view! Post a comment on "ORCHID PHARMA LTD Announces Quarterly Results (2QFY19); Net Profit Up 67.1%". Click here!

  

Related Views on News

ORCHID PHARMA LTD Announces Quarterly Results (4QFY18); Net Profit Up 50.8% (Quarterly Result Update)

Aug 24, 2018 | Updated on Aug 24, 2018

For the quarter ended March 2018, ORCHID PHARMA LTD has posted a net profit of Rs 924 m (up 50.8% YoY). Sales on the other hand came in at Rs 2 bn (down 24.0% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

More Views on News

Most Popular

This Crorepati Stock Could Be the Best Vaccine for Your Portfolio Against Coronavirus(Profit Hunter)

Mar 17, 2020

If there is one stock I had to recommend you amid Coronavirus outbreak, this would be it.

If I Were to Recommend One Stock Amid Coronavirus Outbreak, This Would be It.(Profit Hunter)

Mar 19, 2020

Coronavirus outbreak has made no impact on the long term prospects of my favourite smallcap. What it has indeed done is brought the company below my buy price, making it even more attractive investment at current price.

Why India Will Be the Biggest Winner in a Post-Coronavirus World(The 5 Minute Wrapup)

Mar 19, 2020

The way businesses operate will change in a major way post the coronavirus impact. Here's why India stands to benefit from this change...

A Big Trading Opportunity is Coming Your Way Soon(Fast Profits Daily)

Mar 25, 2020

I see a big opportunity to make fast profits on the horizon.

The Biggest Trading Opportunity of 2020 is Here...

Mar 26, 2020

India's #1 trader, Vijay Bhambwani, talks about a hugely profitable trading opportunity which you must know about today!

More

How to Trade the
Coronavirus Crash

Coronavirus Crash
Get this special report, authored by Equitymaster's top analysts, now.
We will never sell or rent your email id.
Please read our Terms

ORCHID PHARMA LTD SHARE PRICE


Jul 24, 2019 (Close)

TRACK ORCHID PHARMA LTD

  • Track your investment in ORCHID PHARMA LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ORCHID PHARMA LTD

ORCHID PHARMA LTD - ALEMBIC LTD COMPARISON

COMPARE ORCHID PHARMA LTD WITH

MARKET STATS